跳至主要内容
临床试验/NL-OMON45255
NL-OMON45255撤回不适用

Measuring neuromelanin using MRI - Measuring neuromelanin using MRI

Academisch Medisch Centrum0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • Patients with schizofrenia/psycosis:
  • * clinical diagnosis schizophrenia or schizophreniphorm disorder or psychotic episode;Patients with Parkinson's disease
  • * clinical diagnosis Parkinson's disease, strong indication of Parkinson's disease or Parkinsonian symptoms;Healthy controls:
  • * age- and gender matched with patients at group level;All participants:
  • * Capacity to understand the study and to sign *informed consent*.

排除标准

  • Healthy controls:
  • * Severe neurologic and psychiatric disorders
  • * Use of psychotropic drugs or drugs of abuse that may influence the dopamine system;All participants:
  • - contra-indications for MRI (including pacemaker, ferromagnetic implants, possibility of iron splinters in the orbita, claustrophobia )
  • - pregnancy

研究者

相似试验